Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter

被引:129
作者
Treand, Celine
du Chene, Isaure
Bres, Vanessa
Kiernan, Rosemary
Benarous, Richard
Benkirane, Monsef
Emiliani, Stephane
机构
[1] Inst Cochin Genet Mol, Dept Genet & Dev, F-75014 Paris, France
[2] CNRS, UMR 8104, Paris, France
[3] INSERM, U567, Paris, France
[4] Univ Paris 05, Fac Med Rene Descartes, UM 3, Paris, France
[5] CNRS, Inst Genet Humaine, UPR 1142, Montpellier, France
关键词
acetylation; chromatin; HIV-1; SWI/SNF complex; transcription;
D O I
10.1038/sj.emboj.7601074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the human immunodeficiency virus type-1 (HIV-1) promoter in infected cells requires the sequential recruitment of several cellular factors to facilitate the formation of a processive elongation complex. The nucleosomal reorganization of the HIV-1 long terminal repeat (LTR) observed upon Tat stimulation suggests that chromatin-remodeling complexes could play a role during this process. Here, we reported that Tat interacts directly with Brm, a DNA-dependent ATPase subunit of the SWI/SNF chromatin-remodeling complex, to activate the HIV-1 LTR. Inhibition of Brm via small interfering RNAs impaired Tat-mediated transactivation of an integrated HIV-1 promoter. Furthermore, Brm is recruited in vivo to the HIV-1 LTR in a Tat-dependent manner. Interestingly, we found that Tat/Brm interaction is regulated by Tat lysine 50 acetylation. These data show the requirement of Tat-mediated recruitment of SWI/SNF chromatin-remodeling complex to HIV-1 promoter in the activation of the LTR.
引用
收藏
页码:1690 / 1699
页数:10
相关论文
共 55 条
[1]   A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro [J].
Armstrong, JA ;
Bieker, JJ ;
Emerson, BM .
CELL, 1998, 95 (01) :93-104
[2]   The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation [J].
Barker, N ;
Hurlstone, A ;
Musisi, H ;
Miles, A ;
Bienz, M ;
Clevers, H .
EMBO JOURNAL, 2001, 20 (17) :4935-4943
[3]   Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes [J].
Belandia, B ;
Orford, RL ;
Hurst, HC ;
Parker, MG .
EMBO JOURNAL, 2002, 21 (15) :4094-4103
[4]   Activation of integrated provirus requires histone acetyltransferase - p300 AND P/CAF are coactivators for HIV-1 Tat [J].
Benkirane, M ;
Chun, RF ;
Xiao, H ;
Ogryzko, VV ;
Howard, BH ;
Nakatani, Y ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24898-24905
[5]   BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer [J].
Bochar, DA ;
Wang, L ;
Beniya, H ;
Kinev, A ;
Xue, YT ;
Lane, WS ;
Wang, WD ;
Kashanchi, F ;
Shiekhattar, R .
CELL, 2000, 102 (02) :257-265
[6]   Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation [J].
Bourachot, B ;
Yaniv, M ;
Muchardt, C .
EMBO JOURNAL, 2003, 22 (24) :6505-6515
[7]   A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter [J].
Brès, V ;
Kiernan, RE ;
Linares, LK ;
Chable-Bessia, C ;
Plechakova, O ;
Tréand, C ;
Emiliani, S ;
Peloponese, JM ;
Jeang, KT ;
Coux, O ;
Scheffner, M ;
Benkirane, M .
NATURE CELL BIOLOGY, 2003, 5 (08) :754-761
[8]   Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF [J].
Brès, V ;
Tagami, H ;
Péloponèse, JM ;
Loret, E ;
Jeang, KT ;
Nakatani, Y ;
Emiliani, S ;
Benkirane, M ;
Kiernan, RE .
EMBO JOURNAL, 2002, 21 (24) :6811-6819
[9]   Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication [J].
Brès, V ;
Kiernan, R ;
Emiliani, S ;
Benkirane, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22215-22221
[10]   Distinct domains of erythroid Kruppel-like factor modulate chromatin remodeling and transactivation at the endogenous β-globin gene promoter [J].
Brown, RC ;
Pattison, S ;
van Ree, J ;
Coghill, E ;
Perkins, A ;
Jane, SM ;
Cunningham, JM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) :161-170